Suprecur nasal spray
Country: New Zealand
Language: English
Source: Medsafe (Medicines Safety Authority)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Buserelin acetate 1.575 mg/g equivalent to 1.50 mg/mL Buserelin
Available from:
sanofi-aventis new zealand limited
INN (International Name):
Buserelin acetate 1.575 mg/g (= 1.50 mg/mL Buserelin)
Dosage:
150 mcg/dose
Pharmaceutical form:
Nasal spray solution
Composition:
Active: Buserelin acetate 1.575 mg/g equivalent to 1.50 mg/mL Buserelin Excipient: Benzalkonium chloride Citric acid monohydrate Sodium chloride Sodium citrate dihydrate Water for injection
Units in package:
Bottle, glass, 2 x 100 spray doses, 200 dose units
Class:
Prescription
Prescription type:
Prescription
Manufactured by:
Sanofi-Aventis Deutschland GmbH
Product summary:
Package - Contents - Shelf Life: Bottle, glass, 2 x 100 spray doses - 200 dose units - 36 months from date of manufacture stored at or below 25°C
Authorization date:
1993-03-26
